Published on 21st January 2014

Bioquell PLC ("Bioquell") (LSE symbol: BQE) - provider of specialist microbiological control technologies to the international Healthcare, Life Sciences & Defence markets; and specialist testing services in the UK via its TRaC division, today announces that it has appointed Michael Roller (ACA) to be its new Group Finance Director.

Mr Roller has previously been Finance Director of a number of quoted companies, most recently Corin Group plc, has significant experience within the Life Sciences sector and is a non-executive director of Filtronic plc. He has also held a number of other senior finance roles in a broad range of listed and private companies. He qualified as an accountant with KPMG. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Mr Roller's appointment as a director of the Company.

Michael Roller will start work with the Group on 10 February 2014 and will formally assume the role of Group Finance Director on 18 March, following the announcement of the Group's preliminary results for the year ended 31 December 2013.

Commenting on the recruitment of Michael Roller as Group Finance Director, Nigel Keen, Bioquell's Chairman, said:

"We are delighted that Michael has agreed to join Bioquell as Finance Director. He has extensive and highly relevant experience - and we look forward to his contribution to the next stage in the growth of the Group."

Downloads
  • Appointment of Michael Roller as Group Finance Director
distributed by